Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-14.16
↓ 33% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-10.68
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -14.16 | -78.0% |
| 2024 | -7.95 | +0.4% |
| 2023 | -7.98 | +41.0% |
| 2022 | -13.54 | +53.7% |
| 2021 | -29.25 | -285.7% |
| 2020 | -7.58 | -65.5% |
| 2019 | -4.58 | +5.0% |
| 2018 | -4.82 | +47.0% |
| 2017 | -9.10 | -15.6% |
| 2016 | -7.87 | - |